1. Home
  2. Analysis
  3. Minoxidil
  4. Votrient

Minoxidil and Votrient drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Minoxidil (minoxidil) and Votrient (pazopanib hydrochloride). Common drug interactions include diarrhoea among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Minoxidil and Votrient. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Minoxidil?

Minoxidil has active ingredients of minoxidil. It is often used in hair loss. eHealthMe is studying from 29,925 Minoxidil users. Check the latest studies of Minoxidil.

What is Votrient?

Votrient has active ingredients of pazopanib hydrochloride. It is often used in metastatic renal cell carcinoma. eHealthMe is studying from 25,347 Votrient users. Check the latest studies of Votrient.

On Jul, 14, 2026

14 people who take Minoxidil and Votrient together, and have interactions are studied.

Minoxidil and Votrient drug interactions.

What are the common drug interactions of Minoxidil and Votrient, by gender? *:

female:

  1. Diarrhoea
  2. Malignant neoplasm progression (cancer tumour came back)
  3. Renal cancer (cancer of kidney)
  4. Dizziness
  5. Fatigue (feeling of tiredness)
  6. Hypotension (abnormally low blood pressure)

male:

  1. Diarrhoea
  2. Malignant neoplasm progression (cancer tumour came back)
  3. Swelling face
  4. Weight decreased
  5. Abdominal distension
  6. Death
  7. Diarrhoea haemorrhagic (bloody diarrhoea)
  8. Disease progression
  9. Eye swelling
  10. Eyelid oedema (eyelids are swollen and contain excessive fluid)

What are the common drug interactions of Minoxidil and Votrient, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Renal impairment (severely reduced kidney function)
  2. Diarrhoea
  3. Malignant neoplasm progression (cancer tumour came back)

40-49:

n/a

50-59:

n/a

60+:

  1. Death
  2. Disease progression
  3. Dizziness
  4. Eye swelling
  5. Fatigue (feeling of tiredness)
  6. Hypotension (abnormally low blood pressure)
  7. Joint swelling
  8. Swelling face

What are the existing conditions these people have? *

  1. Renal Cell Carcinoma (a kidney cancer): 10 people, 71.43%
  2. High Blood Pressure: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Minoxidil and Votrient?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Minoxidil and Votrient:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Minoxidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Votrient:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Minoxidil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Votrient and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on minoxidil and pazopanib hydrochloride (the active ingredients of Minoxidil and Votrient, respectively), and Minoxidil and Votrient (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.